BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15795934)

  • 1. Systematic administration of iptakalim, an ATP-sensitive potassium channel opener, prevents rotenone-induced motor and neurochemical alterations in rats.
    Yang Y; Liu X; Long Y; Wang F; Ding JH; Liu SY; Sun YH; Yao HH; Wang H; Wu J; Hu G
    J Neurosci Res; 2005 May; 80(3):442-9. PubMed ID: 15795934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats.
    Yang Y; Liu X; Long Y; Wang F; Ding JH; Liu SY; Sun YH; Yao HH; Wang H; Wu J; Hu G
    Int J Neuropsychopharmacol; 2006 Feb; 9(1):51-61. PubMed ID: 15927086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iptakalim modulates ATP-sensitive K(+) channels in dopamine neurons from rat substantia nigra pars compacta.
    Wu J; Hu J; Chen YP; Takeo T; Suga S; Dechon J; Liu Q; Yang KC; St John PA; Hu G; Wang H; Wakui M
    J Pharmacol Exp Ther; 2006 Oct; 319(1):155-64. PubMed ID: 16837559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation of rotenone-induced inflammatory factor production by ATP-sensitive potassium channel expressed in BV-2 cells.
    Liu X; Wu JY; Zhou F; Sun XL; Yao HH; Yang Y; Ding JH; Hu G
    Neurosci Lett; 2006 Feb; 394(2):131-5. PubMed ID: 16257489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP-sensitive potassium channel opener iptakalim protected against the cytotoxicity of MPP+ on SH-SY5Y cells by decreasing extracellular glutamate level.
    Hu LF; Wang S; Shi XR; Yao HH; Sun YH; Ding JH; Liu SY; Hu G
    J Neurochem; 2005 Sep; 94(6):1570-9. PubMed ID: 16000145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of systemic administration of iptakalim on extracellular neurotransmitter levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats.
    Wang S; Hu LF; Zhang Y; Sun T; Sun YH; Liu SY; Ding JH; Wu J; Hu G
    Neuropsychopharmacology; 2006 May; 31(5):933-40. PubMed ID: 16123757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
    Nehru B; Verma R; Khanna P; Sharma SK
    Brain Res; 2008 Mar; 1201():122-7. PubMed ID: 18308296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation.
    Zhou F; Wu JY; Sun XL; Yao HH; Ding JH; Hu G
    Neuropsychopharmacology; 2007 Dec; 32(12):2570-80. PubMed ID: 17356569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new ATP-sensitive potassium channel opener protects endothelial function in cultured aortic endothelial cells.
    Wang H; Long C; Duan Z; Shi C; Jia G; Zhang Y
    Cardiovasc Res; 2007 Feb; 73(3):497-503. PubMed ID: 17116295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release.
    Misaki N; Mao X; Lin YF; Suga S; Li GH; Liu Q; Chang Y; Wang H; Wakui M; Wu J
    J Pharmacol Exp Ther; 2007 Aug; 322(2):871-8. PubMed ID: 17522344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting hypertension with a new adenosine triphosphate-sensitive potassium channel opener iptakalim.
    Pan Z; Huang J; Cui W; Long C; Zhang Y; Wang H
    J Cardiovasc Pharmacol; 2010 Sep; 56(3):215-28. PubMed ID: 20410832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.
    Alam M; Danysz W; Schmidt WJ; Dekundy A
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):198-207. PubMed ID: 19616571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iptakalim protects against MPP+-induced degeneration of dopaminergic neurons in association with astrocyte activation.
    Yang YJ; Zhang S; Ding JH; Zhou F; Hu G
    Int J Neuropsychopharmacol; 2009 Apr; 12(3):317-27. PubMed ID: 18700057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of mitochondrial ATP-sensitive potassium channels increases cell viability against rotenone-induced cell death.
    Tai KK; McCrossan ZA; Abbott GW
    J Neurochem; 2003 Mar; 84(5):1193-200. PubMed ID: 12603842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of iptakalim, a novel ATP-sensitive potassium channel opener, on global cerebral ischemia-evoked insult in gerbils.
    Chen H; Yang Y; Yao HH; Tang XC; Ding JH; Wang H; Hu G
    Acta Pharmacol Sin; 2006 Jun; 27(6):665-72. PubMed ID: 16723083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of iptakalim on rotenone-induced cytotoxicity and dopamine release from PC12 cells.
    Yang Y; Liu X; Ding JH; Sun J; Long Y; Wang F; Yao HH; Hu G
    Neurosci Lett; 2004 Aug; 366(1):53-7. PubMed ID: 15265589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of liver regeneration by adenosine triphosphate-sensitive K⁺ channel opener (diazoxide) after partial hepatectomy.
    Nakagawa Y; Yoshioka M; Abe Y; Uchinami H; Ohba T; Ono K; Yamamoto Y
    Transplantation; 2012 Jun; 93(11):1094-100. PubMed ID: 22466787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of manifestations of diazoxide/5-hydroxydecanoate-sensitive KATP channel in rat brain nonsynaptosomal mitochondria.
    Brustovetsky T; Shalbuyeva N; Brustovetsky N
    J Physiol; 2005 Oct; 568(Pt 1):47-59. PubMed ID: 16051627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iptakalim protects PC12 cell against H2O2-induced oxidative injury via opening mitochondrial ATP-sensitive potassium channel.
    Chai Y; Niu L; Sun XL; Ding JH; Hu G
    Biochem Biophys Res Commun; 2006 Nov; 350(2):307-14. PubMed ID: 17010314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new ATP-sensitive potassium channel opener protects the kidney from hypertensive damage in spontaneously hypertensive rats.
    Xue H; Zhang YL; Liu GS; Wang H
    J Pharmacol Exp Ther; 2005 Nov; 315(2):501-9. PubMed ID: 16051697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.